Performance Comparison
Portfolio Performance Comparison
| Name | YTD Return | 1Yr AR | 3Yr AR | 5Yr AR | 10Yr AR | 15Yr AR | 20Yr AR | Common | Inception |
|---|---|---|---|---|---|---|---|---|---|
| RVNC (Revance Therapeutics, Inc.) | NA | -38.34% | -35.48% | -32.60% | -14.09% | NA | NA | … | … |
Data as of 02/06/2025, Common starting date is 02/07/2014
More Performance Analytics Comparison
| Name | Start Date | End Date |
|---|---|---|
| RVNC (Revance Therapeutics, Inc.) | 02/07/2014 | 02/06/2025 |
| Last 1 Week | 1 Yr | 3 Yr | 5 Yr | 10 Yr | 15 Yr | 20 Yr | Common | Inception | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annualized Return (%) | 0.55 | -38.34 | -35.48 | -32.60 | -14.09 | NA | NA | … | … | 20.07 | -65.19 | -52.38 | 13.11 | -42.41 | 74.61 | -19.03 | -43.69 | 72.71 | -39.40 | 101.65 | -39.50 |
| Sharpe Ratio | NA | -0.39 | -0.44 | -0.42 | -0.22 | NA | NA | … | … | 9.45 | -0.61 | -0.74 | 0.18 | -0.57 | 1.01 | -0.42 | -0.97 | 1.36 | -0.51 | 1.70 | -0.63 |
| Standard Deviation(%) | NA | 115.38 | 90.07 | 83.63 | 72.28 | NA | NA | … | … | 55.96 | 118.95 | 77.45 | 65.75 | 74.18 | 73.03 | 48.84 | 46.49 | 53.17 | 76.99 | 59.93 | 68.14 |
| Draw Down(%) | NA | 67.23 | 93.78 | 93.78 | 94.26 | NA | NA | … | … | 6.34 | 74.87 | 84.55 | 43.53 | 62.48 | 55.20 | 49.88 | 51.71 | 23.11 | 63.26 | 24.53 | 61.72 |
| Yield(%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | … | … | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Data as of 02/06/2025, Common starting date is 02/07/2014
Performance Comparison Chart
Annualized Rolling Returns Comparison (Minimum)
| Ticker/Portfolio Name | 3 Year | 5 Year | 10 Year | 15 Year |
|---|---|---|---|---|
| RVNC (Revance Therapeutics, Inc.) |
-55.74%
Jun 2021 – Jun 2024 |
-30.49%
Jan 2020 – Jan 2025 |
-22.76%
Jun 2014 – Jun 2024 |
0.00%
NA |
Annualized Rolling Returns Comparison (Maximum)
| Ticker/Portfolio Name | 3 Year | 5 Year | 10 Year | 15 Year |
|---|---|---|---|---|
| RVNC (Revance Therapeutics, Inc.) |
29.59%
Mar 2020 – Mar 2023 |
16.86%
Jun 2016 – Jun 2021 |
-11.56%
Oct 2014 – Oct 2024 |
0.00%
NA |
Annualized Rolling Returns Comparison Chart